axa1665
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 30, 2019 (NCT04147936)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04816916 | Phase 2 | Jun 29, 2021 | Axcella Health Inc., University of Pittsburgh |
| NCT04147936 | N/A | Mar 30, 2019 | Axcella Health Inc., Virginia Commonwealth University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Axcella Health Inc. | For profit | 2 | 2 | 2 | 2019 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Virginia Commonwealth University | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1